FTC: Big 3 PBMs generated $7.3B from specialty generic drug markups
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal Trade Commission (FTC) uncovered in its second interim staff report rele | The FTC released its second interim staff report Tuesday during Chair Lina Khan's final open commission meeting,
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
KLBK Lubbock on MSN5h
FTC report highlights prescription drug pricing issues in LubbockPrescription drug prices are rising, and a new report from the Federal Trade Commission (FTC) explains why. Pharmacy benefit ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...
The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...
The Arkansas Pharmacists Association is calling for public and legislative support for stronger regulation of Pharmacy Benefit Managers in Arkansas.PBM's serve ...
UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback